Clinical Updates
Drug approvals, guideline changes, and treatment advances
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Editor's Top Picks
Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial
A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…
Submit Your Paper →
More form Clinical Updates
Multi-arm platform trials could revolutionize neurological disease research
Platform trials could test 15-20 neurological treatments per decade compared to 3-5 using traditional methods.…
Multiple Myeloma Treatment Paradigm Shift: New Guidelines Redefine Early Relapse
New England Journal of Medicine editorial calls for fundamental changes to multiple myeloma early relapse…
New International Guidelines Standardize Ultrasound Monitoring for Post-Surgery Crohn’s Disease Patients
International experts publish new guidelines to standardize intestinal ultrasound monitoring for Crohn's disease patients after…
Bronchial Anthracosis: Coal Dust Exposure Leaves Distinctive Lung Patterns
A New England Journal of Medicine case demonstrates bronchial anthracosis, where coal dust creates distinctive…
Weight Loss Expert Raises Safety Concerns Over Unregulated GLP-1 ‘Microdoses’
Weight-loss specialist warns about unregulated GLP-1 microdosing trend lacking clinical trial evidence. Long-term safety effects…